IGF-I/IGFBPs system response to endotoxin challenge in sheep

Citation
N. Briard et al., IGF-I/IGFBPs system response to endotoxin challenge in sheep, J ENDOCR, 164(3), 2000, pp. 361-369
Citations number
62
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF ENDOCRINOLOGY
ISSN journal
00220795 → ACNP
Volume
164
Issue
3
Year of publication
2000
Pages
361 - 369
Database
ISI
SICI code
0022-0795(200003)164:3<361:ISRTEC>2.0.ZU;2-O
Abstract
Endotoxin (LPS), a membrane component of gram-negative bacteria produces mu ltiple endocrine and metabolic effects that mimic those seen in acute sepsi s. It induces species-dependent alterations of the growth hormone (GH) axis that may participate in the shift of the metabolism towards catabolic even ts. Humans and sheep show increased GH secretion in response to LPS, as opp osed to rats, which have been the most studied. The purpose of our work was to evaluate the effects in intact rams of an acute intravenous administrat ion of a high dose of LPS on the insulin-like growth factor (IGF)-I/IGF-bin ding proteins (IGFBPs) system and to analyse the temporal relationship of G H axis changes with those of several hormonal and metabolic parameters such as somatostatin, cortisol, insulin, and glucose. LPS induced a late moderate decrease of total IGF-I plasma levels following a 5-h steady-state period (-26.6 +/- 4.2%, P<0.05, 9 h after LPS), despite a biphasic and sustained increase of GH secretion in the same animals (2.4 8 +/- 0.39 ng/ml 2 h after LPS and 2.7 +/- 0.37 ng/ml 5 h after LPS vs 0.77 +/- 0.10 before LPS; Briard et al. 1998a). Western ligand blot analysis in IGFBPs showed an early short-lasting increase in IGFBP-1 (188.8 +/- 39% P< 0.05, 3 h after LPS). No significant change was seen for either IGFBP-2, -3 or -4. We observed a marked and sustained increase in cortisol (128.18 +/- 7.21 ng/ml 3 h after LPS, vs 21.17 +/- 4.22 before LPS). Insulin also incr eased (27.69 +/- 3.90 mu U/ml 3 h after LPS, vs 13.48 +/- 1.69 before LPS) and its burst coincided with that of IGFBP-1. Moderately decreased IGF-I and increased IGFBP-1 plasma levels contrasted w ith the sustained increase in GH secretion that we recently described, ther eby suggesting that endotoxin causes a state of resistance to GH. This may be exacerbated by reduced IGF-I bioavailability and/or action, and which ma y participate in the pathophysiology of the catabolic state seen in sepsis. The temporal analysis of hormone responses suggests that endotoxin-induced alterations of the IGF-I/IGFBPs system may involve the prolonged and subst antial somatostatin rise that we recently demonstrated, together with an in crease in glucocorticoid and cytokine as more generally assumed.